Licensing Deals
In the year ending 2006, Isis' three project groups - Life Sciences, Physical Sciences and Business Innovation & Consulting - signed 45 licence and option deals on technologies emerging from research at the University of Oxford.
Isis seeks licensing partners that develop and sell technology-based products, and welcomes contact from companies in all technology and business sectors, in all countries, to discuss commercialisation opportunities.
Details of some of our completed deals can be found in the Isis newsletter. Examples include:
|
Geron - Use of dendritic cells in vaccine delivery and human embryonic stem cell therapies |
|
|
Sequenom - Non-invasive prenatal diagnosis technology |